Claims for Patent: 9,433,219

Summary for Patent: 9,433,219

Title:	Fungi antagonistic to xylella fastidiosa
Abstract:	The disclosure describes fungal organisms and preparations useful for inhibiting infection by Xylella sp. and in the treatment of Pierce\'s Disease.
Inventor(s):	Rolshausen; Philippe (Riverside, CA), Roper; Mary Caroline (Riverside, CA)
Assignee:	The Regents of the University of California (Oakland, CA)
Application Number:	13/452,058
Patent Claims:	1. A composition comprising spores harvested from a pure culture of an endophytic microorganism selected from the group consisting of Aureobasidium sp., Geomyces sp., and a combination thereof, at a concentration of 10.sup.5 to 10.sup.6 spores/mL in sterile water; and a pure culture of Achromobacter sp., wherein the composition inhibits an Xylella fastidiosa infection in a plant. 2. The composition of claim 1, wherein the endoyphtic microorganism is Geomyces sp. 3. The composition of claim 2, wherein the composition is an aqueous media. 4. The composition of claim 1, wherein the plant is selected from grape, oleander, oak, almond, peach, pear, citrus, coffee, maple, mulberry, elm, sycamore, and alfalfa. 5. The composition of claim 4, wherein the plant is grape. 6. The composition of claim 1, wherein the composition is formulated for being delivered into a trunk or stem of a plant. 7. The composition of claim 1, wherein the composition is formulated to be delivered into the xylem of a plant. 8. A composition comprising a pure culture of Achromobacter sp.; and purified ##STR00015##

Details for Patent 9,433,219

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2031-04-20